Media & Resources

Filter by

Type
- All types
- Fact Sheets & Publications
- Features
- IAVI Report
- In The News
- Podcasts
- Press Releases
- Scientific Publications
- Vaccine Literacy Library
- Videos
Health area
- Clinical trials(2)
- COVID-19(58)
- Ebola Sudan(42)
- EID(2)
- Global access(9)
- HIV(360)
- Lassa fever(25)
- Malaria(1)
- Marburg(16)
- Other(101)
- Sexually transmitted infections(1)
- Snakebite(6)
- TB(1)
- Tuberculosis(71)
- Vaccine research(10)
Location
- Africa(216)
- Europe(28)
- Global(419)
- India(15)
- United States(18)
- US(5)
- USA(2)
- Washington(1)
Topic
- Access(19)
- Antibodies(78)
- Capacity strengthening(13)
- Clinical trials(93)
- Community engagement(40)
- Emerging infectious diseases(1)
- Epidemiology(42)
- Funding(31)
- Germline targeting(5)
- Global access(7)
- Key populations(8)
- Pandemic preparedness(27)
- Partnerships(36)
- People(55)
- Policy and advocacy(41)
- Regulatory pathways(6)
- Social-behavioral research(3)
- Vaccine research(202)
Year
Journal
- Acta Crystallogr. D Biol. Crystallogr.(1)
- Addict Behav Rep(1)
- Afr J Lab Med(1)
- AIDS(41)
- AIDS Behav(9)
- AIDS Behav.(1)
- AIDS Care(5)
- AIDS Patient Care STDS(1)
- AIDS Res Hum Retroviruses(25)
- AIDS Res Ther(1)
- Am J Mens Health(1)
- Am J Public Health(1)
- Anal. Biochem.(1)
- Angew. Chem. Int. Ed. Engl.(2)
- Ann. Hum. Genet.(1)
- Ann. Intern. Med.(1)
- Ann. N. Y. Acad. Sci.(1)
- Ann. Oncol.(1)
- Annu. Rev. Immunol.(1)
- Annu. Rev. Med.(1)
- Biochemistry(3)
- Biologicals(3)
- Biomolecules(1)
- Biores Open Access(1)
- bioRxiv(1)
- Biotechnol Bioeng(2)
- Biotechnol J(1)
- Blood(1)
- BMC Biochem.(1)
- BMC Health Serv Res(2)
- BMC Immunol.(1)
- BMC Infect Dis(6)
- BMC Infect Dis.(1)
- BMC Med(2)
- BMC Med Educ(1)
- BMC Med Res Methodol(1)
- BMC Public Health(7)
- BMC Res Notes(1)
- BMC Womens Health(2)
- BMJ Glob Health(1)
- BMJ Open(2)
- Br. Med. Bull.(1)
- Bull. World Health Organ.(1)
- Campbell Syst Rev(1)
- Cell(10)
- Cell Chem Biol(1)
- Cell Host Microbe(2)
- Cell Rep(15)
- Chem Asian J(1)
- Chem. Biol.(1)
- Chem. Commun. (Camb.)(1)
- Clin Infect Dis(4)
- Clin. Vaccine Immunol.(3)
- Cogent Med(1)
- Contemp Clin Trials Commun(1)
- Contraception(3)
- Cult Health Sex(1)
- Curr Opin HIV AIDS(5)
- Curr. HIV Res.(1)
- Curr. Opin. Biotechnol.(1)
- Curr. Opin. Immunol.(3)
- Curr. Opin. Mol. Ther.(1)
- Curr. Opin. Struct. Biol.(1)
- Curr. Pharm. Des.(1)
- Curr. Top. Microbiol. Immunol.(1)
- Current Opinion in HIV and AIDS(1)
- East Afr Med J(2)
- eBioMedicine(1)
- Elife(1)
- Epidemiol. Infect.(1)
- Epidemiology(1)
- Eur. J. Immunol.(2)
- Expert Rev Vaccines(7)
- FASEB J.(1)
- Front Cell Infect Microbiol(1)
- Front Immunol(14)
- Front Microbiol(2)
- Front Public Health(1)
- Front Reprod Health(2)
- Gene Ther.(1)
- Genes Immun.(3)
- Global Health(1)
- Glycobiology(3)
- Health Aff (Millwood)(2)
- Health Policy(1)
- Health Promot Int(1)
- Health Res Policy Syst(1)
- HIV Med(1)
- Hum Vaccin(2)
- Hum Vaccin Immunother(2)
- Hum. Genet.(1)
- Human Vaccines & Immunotherapeutics(1)
- IJID Reg(1)
- Immunity(29)
- Immunol. Rev.(4)
- Indian J Pediatr(2)
- Indian J. Med. Res.(4)
- Int Health(3)
- Int J Epidemiol(2)
- Int J Med Inform(2)
- Int J STD AIDS(4)
- J Adv Manuf Process(1)
- J Antimicrob Chemother(1)
- J Comput Chem(1)
- J Family Med Prim Care(1)
- J HIV AIDS Surveill Epidemiol(1)
- J Immunol(16)
- J Infect Dis(16)
- J Int AIDS Soc(14)
- J Pharm Sci(1)
- J Womens Health (Larchmt)(1)
- J. Acquir. Immune Defic. Syndr.(16)
- J. Am. Chem. Soc.(3)
- J. Am. Soc. Mass Spectrom.(1)
- J. Biol. Chem.(9)
- J. Clin. Invest.(2)
- J. Clin. Microbiol.(1)
- J. Exp. Med.(11)
- J. Gen. Virol.(11)
- J. Hepatol.(1)
- J. Immunol. Methods(9)
- J. Med. Primatol.(1)
- J. Mol. Biol.(6)
- J. Pept. Sci.(1)
- J. Virol.(114)
- J. Virol. Methods(2)
- JCI Insight(1)
- JMIR Res Protoc(1)
- Lancet(12)
- Lancet Glob Health(1)
- Lancet HIV(3)
- Lancet Infect Dis(2)
- lancet microbe(1)
- mBio(3)
- medRxiv(1)
- Methods Mol. Med.(1)
- Microbiol Spectr(2)
- Microorganisms(1)
- Mol Ther Methods Clin Dev(1)
- Mol. Ther.(2)
- Mucosal Immunol(1)
- N. Engl. J. Med.(7)
- Nat Commun(17)
- Nat Immunol(2)
- Nat Med(15)
- Nat Microbiol(2)
- Nat. Biotechnol.(1)
- Nat. Chem. Biol.(1)
- Nat. Immunol.(5)
- Nat. Rev. Immunol.(1)
- Nat. Rev. Microbiol.(1)
- Nat. Struct. Mol. Biol.(4)
- Nature(20)
- npj Vaccines(1)
- Nucleic Acids Res.(1)
- Open Forum Infect Dis(2)
- Org. Biomol. Chem.(1)
- Orphanet J Rare Dis.(1)
- Pan Afr Med J(3)
- PDA J Pharm Sci Technol(1)
- Pharmaceut Med(1)
- Pharmacoeconomics(2)
- PLoS Glob Public Health(6)
- PLoS Med.(5)
- PLoS Negl Trop Dis(1)
- PLoS One(84)
- PLoS Pathog(36)
- Proc Natl Acad Sci U S A(30)
- Proteins(1)
- Proteomics(2)
- Rapid Commun. Mass Spectrom.(1)
- Res Involv Engagem(1)
- Retrovirology(13)
- Rev. Med. Virol.(1)
- S. Afr. Med. J.(1)
- Sci Adv(2)
- Sci Immunol(2)
- Sci Rep(8)
- Sci Transl Med(9)
- Science(35)
- Sex Health(1)
- Sex Transm Dis(4)
- Sex Transm Infect(12)
- Southeast Asian J. Trop. Med. Public Health(1)
- Springerplus(1)
- Structure(3)
- Stud Fam Plann(1)
- Syst Rev(1)
- Ther Adv Vaccines(1)
- Top HIV Med(1)
- Toxins(1)
- Trends Microbiol.(1)
- Trends Parasitol(1)
- Trop Dis Travel Med Vaccines(1)
- Trop. Med. Int. Health(7)
- Vaccine(32)
- Vaccines (Basel)(3)
- Virology(36)
- Viruses(1)
- Wellcome Open Res(1)
- Women's Health (Lond)(1)
Publication
- AARP(1)
- ABC 10 News in San Diego,(1)
- ABC News(1)
- ABCNEWS(1)
- AFP News(1)
- AIDSmap(1)
- ANI(1)
- Apna Radio 96.9 fm(1)
- AVAC(1)
- BBC(1)
- BioSpace,(1)
- BioWorld,(1)
- Bloomberg(4)
- Bloomberg Businessweek(1)
- BNN Bloomberg(1)
- Business Daily(1)
- Business Insider(2)
- CEPI(2)
- CGTN(1)
- Chemical & Engineering News(1)
- CIDRAP(4)
- Clinical Trials Arena(2)
- CNBC(1)
- CNN(4)
- CNN International(1)
- Contagion Live(1)
- Cope,(1)
- CSIS(1)
- CSIS Global Health Policy Center(1)
- Daily Mail(1)
- Daily Maverick(1)
- Daily Nation(2)
- Devex(5)
- Drug Discovery & Development,(1)
- Ebru TV (video)(1)
- Economic Times(1)
- El Confidencial(1)
- El Español,(1)
- El Global,(1)
- El País(2)
- EndPoints News(1)
- Es Radio Albacete,(1)
- ETHealthWorld (video)(1)
- EU Observer(1)
- European Commission(1)
- Fierce Pharma,(1)
- Financial Times(1)
- Fox News,(1)
- Gavi(6)
- GEN,(1)
- Genetic Engineering & Biotechnology News(1)
- Global Health NOW(1)
- HCP Live,(1)
- Health Affairs,(1)
- Health Analytics Asia(1)
- Health Policy Watch(2)
- Hutch News Service(1)
- Indian Express(2)
- International Business Times,(1)
- International Development Research Centre(1)
- La Razón(1)
- La Razón,(1)
- La Tribuna de Albacete(1)
- La Voz de Galicia(1)
- Le Monde(1)
- Los Angeles Times(2)
- Managed Healthcare Executive(1)
- Medical New Today(1)
- MedPage Today(1)
- Memorias(1)
- mosaic(1)
- Nasdaq,(1)
- National Geographic(1)
- National Review(1)
- Nature(5)
- Nature India(1)
- New Scientist(1)
- News 18 India(1)
- Newsweek(1)
- NIAID(1)
- Nigerian Television Authority(1)
- NPR Goats & Soda(1)
- NPR Goats and Soda(1)
- Person Place Thing (podcast)(1)
- PharmaVoice(1)
- Politico(1)
- Popular Science(1)
- Posterity Media(1)
- Precision Vaccinations,(1)
- ProPatiens(1)
- ProPatients(2)
- Refinery 29(1)
- Results UK(1)
- Reuters(2)
- Reuters,(1)
- Rolling Stone(1)
- Salon(2)
- Sayansi Magazine(1)
- SciDevNet,(2)
- Science(9)
- ScienceNews(1)
- Scroll.in(1)
- Spotlight(1)
- Standard(1)
- STAT(7)
- STAT News(13)
- STAT Plus (Subscription Required)(2)
- TechCrunch,(1)
- Telecinco,(2)
- The Associated Press(1)
- The BMJ(1)
- The Conversation(1)
- The Daily Nation(2)
- The Guardian(2)
- The Guardian Nigeria(2)
- The HILL(3)
- The Indian Express(1)
- THE LANCET(3)
- The New Times(1)
- The New York Times(3)
- The Observer(1)
- The Standard(1)
- The Telegraph(4)
- The Voice of America(1)
- The Wall Street Journal(1)
- The Washington Post(2)
- The Wire(2)
- them.(1)
- Times of India(2)
- USAID Blog(1)
- Vaccine Insights(1)
- VaccinesToday(1)
- VICE(1)
- Wall Street Journal,(1)
- WebMD(1)
- WIRED(1)
- World Health Organization(2)
- World Pharmaceutical Frontiers(1)
- Yale School of Medicine(1)
- Zendal(1)
Fact sheet & publication type
- Annual Reports(6)
- Community Engagement Resources(15)
- Fact Sheets(9)
- Policy and Advocacy Publications(18)
Keyword search
Clear all

Features

IAVI’s Human Immunology Laboratory relocates samples to Africa, fulfilling capacity strengthening goal

May 7, 2024

Lab to close June 30, 2024.

Scientific Publications

Review of Current Tuberculosis Human Infection Studies for Use in Accelerating Tuberculosis Vaccine Development: A Meeting Report

Features

TB vaccine workshop report published in Frontiers in Tuberculosis

May 2, 2024

Workshop examined high-burden country data needs for future TB vaccine introduction.

IAVI Report

Rethinking antibodies for infectious diseases?

April 23, 2024

The COVID-19 experience, along with lingering manufacturing and delivery concerns, is prompting a harder look at the future of antibody-based treatment and prevention for infectious diseases.

Scientific Publications

The role of economic evaluations in advancing HIV multipurpose prevention technologies in early-stage development

In The News

Nigerians vaccinated in maiden Lassa fever vaccine clinical trial

The Guardian Nigeria

April 5, 2024

Press Releases

Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial, sponsored by IAVI

April 4, 2024

The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI’s single dose Lassa fever vaccine candidate.

Scientific Publications

Safety and immunogenicity of the H56:IC31 tuberculosis vaccine candidate in adults successfully treated for drug-susceptible pulmonary TB: a phase 1 randomized trial

1…18 192021 22…233 of 233

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

IAVI’s Human Immunology Laboratory relocates samples to Africa, fulfilling capacity strengthening goal

Review of Current Tuberculosis Human Infection Studies for Use in Accelerating Tuberculosis Vaccine Development: A Meeting Report

TB vaccine workshop report published in Frontiers in Tuberculosis

Rethinking antibodies for infectious diseases?

The role of economic evaluations in advancing HIV multipurpose prevention technologies in early-stage development

Nigerians vaccinated in maiden Lassa fever vaccine clinical trial

Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial, sponsored by IAVI

Safety and immunogenicity of the H56:IC31 tuberculosis vaccine candidate in adults successfully treated for drug-susceptible pulmonary TB: a phase 1 randomized trial

Subscription Type